Archive for January 2018
Voyager Founder and CEO to Step Down, Hunt for New Leader Begins
Dr. Paul has been with the company for six years since its inception, initially as president of R&D, Source: BioSpace
Read MoreStada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016
Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace
Read MoreCambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic
The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease. Source: BioSpace
Read MoreInvestors Elated as Vertex Picks Two Top CF Triple Combos for Phase III Trials
Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy. Source: BioSpace
Read MoreLilly Exploring Strategic Alternatives for Animal Health Biz
Sluggish growth is the main driver for the decision.. Source: BioSpace
Read MoreBooming Celltrion Falls After FDA Warning Letter
Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility. Source: BioSpace
Read MoreTrump's CDC Director Resigns Over Pharma, Tobacco Investments
Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace
Read MoreNewcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace
Read More3 FDA Decisions to Look Out for in February
Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace
Read MoreTeva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital
The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace
Read More